How the lungs can make DMT
DMT, short for N,N-dimethyltryptamine, is a molecule the body can assemble from tryptamine, a compound related to the building blocks of several neurotransmitters. Enzymes—proteins that speed up chemical reactions—can add two methyl groups to tryptamine, using a molecule called SAM as the source of those groups. Enzymes involved in this pathway have been found in lung tissue, making the lungs a plausible site of production.
That does not mean the lungs store a supply of DMT or release it in a dramatic burst. The body also breaks DMT down quickly, chiefly through the enzyme monoamine oxidase. Production, breakdown, and the amount reaching any particular part of the body all affect what a trace measurement means.
Why trace production is not a psychedelic trip
A psychedelic effect depends not simply on whether a molecule exists in the body, but on how much reaches the brain and how it interacts with brain-cell receptors. The amounts the body may produce are not known to reach levels that cause spontaneous psychedelic experiences. Finding a molecule in tissue is therefore very different from showing that it changes perception.
DMT’s presence in the body has inspired speculation about dreams, near-death experiences, and mystical states. Those ideas remain hypotheses, not established explanations: evidence that the body can make small amounts does not show that DMT causes those experiences. The striking point is more modest—and more concrete: a molecule often associated with powerful external drug effects can also be part of ordinary body chemistry, without those effects following automatically.
